Natural Alternatives International Inc. (NAII) Stock Price

NAIIStock

$1.15−57.25%52W

Market Cap$7.20M

P/E—

PEG Ratio5.41

Div yield—

Beta0.41

NAII Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-68.09%

Price vs S&P 500 (4W)-37.18%

PEG Ratio5.41

VGM Score52.84

P/CF (Annual)1.52x

Book Value / Share (Quarterly)$7.97

P/TBV (Annual)2.41x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-2.55%

Cash Flow / Share (Quarterly)$-2.01

Price vs S&P 500 (YTD)-79.80%

Gross Margin (TTM)6.31%

Net Profit Margin (TTM)-14.52%

EPS (TTM)$-3.42

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$-3.42

Revenue Growth (5Y)-4.40%

EPS (Annual)$-3.43

ROI (Annual)-30.15%

Gross Margin (Annual)6.31%

Net Profit Margin (5Y Avg)-4.69%

Cash / Share (Quarterly)$1.18

Revenue Growth QoQ (YoY)1.90%

ROA (Last FY)-16.37%

Revenue Growth TTM (YoY)9.75%

EBITD / Share (TTM)$-2.33

ROE (5Y Avg)-11.02%

Operating Margin (TTM)-13.16%

Cash Flow / Share (Annual)$-2.01

P/B Ratio0.14x

P/B Ratio (Quarterly)0.30x

Net Income / Employee (Annual)$-70,600

EV / Revenue (TTM)0.13x

Net Interest Coverage (TTM)-12.96x

ROA (TTM)-13.99%

EV / EBITDA (TTM)10.26x

EPS Incl Extra (Annual)$-3.43

Current Ratio (Annual)1.73x

Quick Ratio (Quarterly)0.85x

3-Month Avg Trading Volume0.04M

52-Week Price Return-57.25%

EV / Free Cash Flow (Annual)8.00x

Revenue / Employee (TTM)$486,400

Tangible BV / Share (Quarterly)$3.79

P/S Ratio (Annual)0.05x

Asset Turnover (Annual)1.13x

52-Week High$4.96

Operating Margin (5Y Avg)-3.25%

EPS Excl Extra (Annual)$-3.43

CapEx CAGR (5Y)-6.25%

Tangible BV CAGR (5Y)5.40%

26-Week Price Return-58.18%

Quick Ratio (Annual)0.85x

13-Week Price Return-48.20%

Total Debt / Equity (Annual)0.37x

Current Ratio (Quarterly)1.73x

Enterprise Value$18.52M

Revenue / Share Growth (5Y)-3.25%

Asset Turnover (TTM)0.96x

Book Value / Share Growth (5Y)-8.63%

Revenue / Employee (Annual)$486,400

Inventory Turnover (Annual)4.80x

Pretax Margin (Annual)-14.22%

Cash / Share (Annual)$1.18

3-Month Return Std Dev64.49%

Gross Margin (5Y Avg)9.83%

Net Income / Employee (TTM)$-70,600

ROE (Last FY)-41.42%

Net Interest Coverage (Annual)-12.96x

EPS Basic Excl Extra (Annual)$-3.43

P/FCF (TTM)2.19x

Receivables Turnover (TTM)8.08x

Total Debt / Equity (Quarterly)0.37x

EPS Incl Extra (TTM)$-3.42

Receivables Turnover (Annual)8.08x

ROI (TTM)-26.50%

P/S Ratio (TTM)0.05x

Pretax Margin (5Y Avg)-4.09%

Revenue / Share (Annual)$23.64

Tangible BV / Share (Annual)$4.42

Price vs S&P 500 (52W)-72.78%

Year-to-Date Return-67.88%

5-Day Price Return-5.74%

EPS Normalized (Annual)$-3.43

ROA (5Y Avg)-4.11%

Net Profit Margin (Annual)-14.52%

Month-to-Date Return-22.82%

Cash Flow / Share (TTM)$0.89

EBITD / Share (Annual)$-2.33

Operating Margin (Annual)-13.16%

LT Debt / Equity (Annual)0.20x

ROI (5Y Avg)-8.29%

LT Debt / Equity (Quarterly)0.20x

EPS Basic Excl Extra (TTM)$-3.42

P/TBV (Quarterly)2.37x

P/B Ratio (Annual)0.30x

Inventory Turnover (TTM)4.80x

Pretax Margin (TTM)-14.22%

Book Value / Share (Annual)$7.97

Price vs S&P 500 (13W)-50.88%

Beta0.41x

P/FCF (Annual)3.11x

Revenue / Share (TTM)$23.47

ROE (TTM)-33.23%

52-Week Low$1.08

vGradeA

gGradeC

mGradeD

vgmGradeC

NAII Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2026	May 19, 2026	—	-$0.72	—

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
NAIINatural Alternatives International Inc.	A	C	D	0.1x	9.8%	6.3%	—	$1.15
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	B	—	—	—	—	$9.59
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	B	—	—	—	—	$32.10
TRLVTrulieve Cannabis Corp.	B	C	A	1.7x	-3.9%	59.5%	—	$10.01
CRONCronos Group Inc. Common Share	C	B	A	6.6x	37.5%	46.5%	-50.0%	$3.21
TLRYTilray Brands, Inc. Common Stock	B	B	D	0.5x	15.9%	29.1%	—	$3.04
CGCCanopy Growth Corporation Common Shares	B	C	D	1.6x	6.8%	28.5%	—	$0.71
SNDLSundial Growers Inc. Common Shares	B	C	B	0.5x	-1.7%	26.2%	—	$1.25
GLASGlass House Brands Inc.	B	C	D	1.2x	-25.6%	30.8%	—	$3.19
USNAUSANA Health Sciences Inc	B	D	C	0.3x	5.7%	77.5%	-37.0%	$15.54
ACBAurora Cannabis Inc. Common Shares	B	D	B	1.3x	-18.9%	6.3%	—	$3.99
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	1.5x	11.0%	64.2%	—	$2.49
MDWDMediWound Ltd.	D	F	C	12.9x	-40.3%	15.5%	—	$11.85
FTLFFitLife Brands, Inc. Common Stock	B	C	C	0.8x	17.0%	36.5%	-20.0%	$8.39
BTMDBiote Corp. Class A Common Stock	A	D	D	0.2x	-7.8%	68.6%	-26.8%	$1.08
MTEXMannatech Inc.	B	D	B	0.1x	-5.0%	76.1%	-0.8%	$7.13
BONBon Natural Life Limited Class A Ordinary Shares	A	D	C	0.5x	-12.9%	22.1%	—	$1.14
AKANAkanda Corp. Common Shares	C	F	F	12.2x	-63.1%	-60.5%	—	$1.20
IMCCIM Cannabis Corp. Common Shares	A	B	F	0.1x	12.7%	18.6%	—	$1.39
SNYRSynergy CHC Corp. Common Stock	A	C	F	0.0x	8.3%	65.4%	118.4%	$0.03
MEHAFunctional Brands, Inc. Common Stock	A	C	C	0.0x	—	53.7%	—	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	B	—	—	—	—	$23.11

About Natural Alternatives International Inc.

Natural Alternatives International is a nutritional supplement and healthcare product manufacturer serving U.S. and international markets through contract manufacturing and licensing. Its Private-Label Contract Manufacturing segment, the primary revenue driver, manufactures supplements and healthcare products for third-party distributors. The company also generates royalty income through patent and trademark licensing agreements.